Two years after the launch of the Canadian Drug Shortage
Database, Health Canada is now seeking input on the current
approach to addressing drug shortages in Canada. A six-week public
consultation period has been initiated and runs from May 22, 2014
to July 5, 2014.
In a previous
Pharma in Brief bulletin, we summarized Health Canada's
initiative to prevent and reduce the impact of drug shortages in
Canada. This initiative included the Protocol for the
Notification and Communication for Drug Shortages and
Multi-Stakeholder Toolkit for Improved Understanding and
Transparency of Drug Shortage Response in Canada.
Canadian drug shortage database
The Drug Shortages Database was launched in March 2012; it is an
industry-led database aimed at providing Canadians with information
about actual and anticipated drug shortages and supply disruptions.
The rationale for implementation of the system is that timely and
accurate notification of drug shortages or disruptions is required
in order for the healthcare system to react and address the effects
of a drug shortage.
Although participation in the notification of drug shortages is
voluntary, Canadian pharmaceutical manufacturers and importers are
expected to post information on all actual and anticipated drug
shortages and discontinuances on the online database. Under the
current policy, information should be posted as early as
In this consultation, Health Canada is seeking to determine how
well the current system is working with a view to addressing
concerns going forward. Health Canada is seeking feedback from the
general public as well as industry stakeholders including
manufacturers, distributors, importers, industry organizations,
pharmacists and other health care professionals.
Participation in the consultation process can be done by email,
mail or through Health Canada's online submission process. More
information on the submission process can be found through the
website link below.
Norton Rose Fulbright is a global legal practice. We provide
the world's pre-eminent corporations and financial institutions
with a full business law service. We have more than 3800 lawyers
based in over 50 cities across Europe, the United States, Canada,
Latin America, Asia, Australia, Africa, the Middle East and Central
Recognized for our industry focus, we are strong across all
the key industry sectors: financial institutions; energy;
infrastructure, mining and commodities; transport; technology and
innovation; and life sciences and healthcare.
Wherever we are, we operate in accordance with our global
business principles of quality, unity and integrity. We aim to
provide the highest possible standard of legal service in each of
our offices and to maintain that level of quality at every point of
Norton Rose Fulbright LLP, Norton Rose Fulbright Australia,
Norton Rose Fulbright Canada LLP, Norton Rose Fulbright South
Africa (incorporated as Deneys Reitz Inc) and Fulbright &
Jaworski LLP, each of which is a separate legal entity, are members
('the Norton Rose Fulbright members') of Norton Rose
Fulbright Verein, a Swiss Verein. Norton Rose Fulbright Verein
helps coordinate the activities of the Norton Rose Fulbright
members but does not itself provide legal services to
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
To print this article, all you need is to be registered on Mondaq.com.
Click to Login as an existing user or Register so you can print this article.
Effective September 1, 2016, the Disposition of Surplus Real Property Regulation to the Ontario Education Act was amended with the intention to reduce barriers to the formation of health and community hubs in Ontario.
This appeal relates to two generic drug submissions for two different products: exemestane and infliximab. Both submissions cross-referenced the submission of another generic company that had received a Notice of Compliance.
Two recent decisions from the Supreme Court of Canada directly affect Quebec's farm businesses by confirming La Financière Agricole du Québec's discretion in the administration of the farm income stabilization program...
On October 6, 2016, the Ontario Legislature reintroduced the Patients First Act, 2016 as Bill 41. Bill 41 is very similar to its predecessor, Bill 210, which was introduced in June 2016, but makes some important changes to the previous bill.
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).